managerShanghai synvida bio.techShanghai, Shanghai, China (People's Republic)
OC 49.4 - An effective and safe strategy for anti-thrombosis therapy by monoclonal antibody blocking the interaction of FIXa with FVIIIa
Monday, June 24, 202415:30 – 15:45 ICT